Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
Recalled Product
Sotrovimab, 500 mg IV
Hazard / Issue
New safety information - COVID
Issued by
Marketed health products
Were you affected by this recall?
If you were harmed by a recalled product, you may have legal options. Consider speaking with a consumer protection lawyer in your province.
Looking for safe alternatives?
Browse certified-safe products in this category on Amazon Canada →
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime